Showing results (1-10 of 184) with videos related to
Sort By:
Pageof 19
Advanced Drug Delivery Reviews|July 14, 2020
Progress and challenges towards CRISPR/Cas clinical translationDaniel Rosenblum, Anna Gutkin, Niels Dammes, et al.Cancer Letters|August 15, 2013
Omics-based nanomedicine: the future of personalized oncologyDaniel Rosenblum, Dan PeerExpert Opinion on Drug Delivery|June 14, 2016
Harnessing nanomedicine for therapeutic intervention in glioblastomaAnna Gutkin, Zvi R Cohen, Dan PeerJournal of Drug Targeting|October 9, 2018
Targeting central nervous system pathologies with nanomedicinesShoshy Mizrahy, Anna Gutkin, Paolo Decuzzi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 25, 2021
Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticlesLiyona Kampel, Meir Goldsmith, Srinivas Ramishetti, et al.Methods in Molecular Biology (Clifton, N.J.)|May 18, 2019
Systemic Modulation of Lymphocyte Subsets Using siRNAs Delivered via Targeted Lipid NanoparticlesInbal Hazan-Halevy, Daniel Rosenblum, Srinivas Ramishetti, et al.Nature Communications|April 14, 2018
Progress and challenges towards targeted delivery of cancer therapeuticsDaniel Rosenblum, Nitin Joshi, Wei Tao, et al.Science Advances|November 19, 2020
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapyDaniel Rosenblum, Anna Gutkin, Ranit Kedmi, et al.Cancer Letters|May 3, 2015
Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytesInbal Hazan-Halevy, Daniel Rosenblum, Shiri Weinstein, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 6, 2016
Immunomodulation of hematological malignancies using oligonucleotides based-nanomedicinesInbal Hazan-Halevy, Dalit Landesman-Milo, Daniel Rosenblum, et al.Pageof 19